Medical Director, Clinical Development, Allergy & Immunology
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director, Clinical Development to join our Clinical Development team, supporting Regeneron-driven studies within our growing therapeutics organization. In this role, you will provide clinical leadership across assigned protocols and study conduct issues while collaborating with the Clinical Program Lead, Clinical Sciences and cross-functional study teams. This position offers the opportunity to shape research and development programs for early and late-stage assets, contributing to a fast-growing, science-driven organization making a meaningful difference for patients worldwide.
Job description
When & where:
- Location: Tarrytown, NY
- Travel: 10% to relevant conferences and congresses
Discover your role:
- Provide clinical leadership for all deliverables within your assigned section of a clinical program, including protocols, regulatory documents, and publications
- Facilitate assigned studies and support investigators on Regeneron-driven trials
- Anticipate and resolve clinical and study conduct issues as they arise
- Initiate, propose, design, and execute research and development programs for early and late-stage assets
- Influence team decisions and drive alignment across functions in a matrix environment
- Communicate clear, concise messages through proficient medical writing and advanced presentation skills
- Identify critical risks to studies and programs and propose mitigation strategies
- Engage colleagues at all levels, internally and externally, with professional diplomacy and cultural awareness
This role requires:
- M.D. degree or equivalent
- 0-4 years of clinical development experience in industry preferred; academic research experience will also be considered
- Specialized clinical fellowship training in Allergy, Immunology, Infectious Disease, Pulmonology, or Dermatology strongly preferred
- Proficient knowledge of the drug development process, Good Clinical Practice, study design, and research methodology
- Understanding of the regulatory and compliance landscape in the pharmaceutical industry
- Advanced analytical, influencing, and communication skills
Requirements
- M.D. degree or equivalent
- 0-4 years of clinical development experience in industry preferred; academic research experience will also be considered
- Specialized clinical fellowship training in Allergy, Immunology, Infectious Disease, Pulmonology, or Dermatology strongly preferred
- Proficient knowledge of the drug development process, Good Clinical Practice, study design, and research methodology
- Understanding of the regulatory and compliance landscape in the pharmaceutical industry
- Advanced analytical, influencing, and communication skills
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.